Skip to main content

Advertisement

SpringerLink
Log in

The chemotherapy of posterior Fossa tumors in childhood

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Conventional therapy for brain tumors, consisting of neurosurgical intervention and radiotherapy, has not resulted in the successes achievable in other childhood malignancies. The role of adjuvant chemotherapy, well defined in many childhood cancers, has not yet contributed significantly to the treatment of children with brain tumors. Chemotherapy of recurrent tumors has produced regressions but no cures. The most active agents identified to date in the treatment of recurrent posterior fossa tumors include cisplatinum, cyclophosphamide and methotrexate. Future efforts will need to focus on the rational selection of drugs for study in limited agent histology-stratified phase II trials, with advancement of active agents into large randomized phase III adjuvant therapy trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Silverberg E: Cancer Statistics. Cancer 31:13–28, 1981

    Google Scholar 

  2. Farwell R, Dohrmann GJ, Flannery JT: Central nervous system tumors in children. Cancer 40:3123–3132, 1977

    Google Scholar 

  3. Cushing H: Experiences with the cerebellar medulloblastomas: A critical review. Acta Pathol Microbiol Scand 1:1–86, 1930

    Google Scholar 

  4. Bloom HFG: Medulloblastoma in children: Increasing survival rates and further prospects. Int J Radiat Oncol Biol Phys 8:2023–2027, 1982

    Google Scholar 

  5. Zeltzer PM, Friedman HS, Norris DG, Ragab A: Criteria and definitions for response and relapse in children with brain tumors. Cancer 56:1824–1826, 1985

    Google Scholar 

  6. Gyepes MT, D'Angio: Extracranial metastases from CNS tumors in children and adolescent. Radiology 87:55–63, 1966

    Google Scholar 

  7. Benjamin RS, Wiernik PH, Bachur NR: Adriamycin chemotherapy-efficacy, safety, and pharmacologic basis of an intermittent, single high-dose schedule. Cancer 33:19–27, 1974

    Google Scholar 

  8. Edwards MS, Levin VA, Seager ML, Wilson CB: Intrathecal chemotherapy for leptomeningeal dissemination of medulloblastoma. Child's Brain 8:444–451, 1981

    Google Scholar 

  9. Schold SC, Friedman HS, Bjornsson TD, Falletta JM: Treatment of patients with recurrent primary brain tumors with AZQ. Neurology 34:615–619, 1984

    Google Scholar 

  10. Walker MD, Hurwitz BS: BCNU (1,3-Bis(2-chloroethyl)-1-Nitrosourea) in the treatment of malignant brain tumor —A preliminary report. Cancer Chemother Rep 54:263–271, 1970

    Google Scholar 

  11. Fewer D, Wilson CB, Boldrey EB, Enot KJ, Powell MP: Chemotherapy of brain tumors - clinical experience with carmustine and vincristine. JAMA 222:549–552, 1972

    Google Scholar 

  12. Shapiro WR: Chemotherapy of primary malignant brain tumors. Cancer in Children 35:965–972, 1975

    Google Scholar 

  13. Walker RW, Allen JC, Bacha D, Tan C: Treatment of recurrent primary brain tumors of childhood with carboplatin. Ann Neurology 18:406, 1985

    Google Scholar 

  14. Fewer D, Wilson CB, Boldrey EB, Enot JK: Phase 11 study of 1-(2-chloroethyl)-3-cyclohexyl-l-nitrosourea (CCNU) in the treatment of brain tumors. Cancer Chemother Rep 56:421–427, 1972

    Google Scholar 

  15. Rosenblum ML, Reynolds AF, Smith KA, Rumack BH, Walker MD: Chloroethyl-cyclohexyl-nitrosourea (CCNU) in the treatment of malignant brain tumors. J Neurosurg 39:306–314, 1973

    Google Scholar 

  16. Shapiro WR, Cheromme NL, Posner JB: Necrotizing encephalopathy following intraventricular instillation of methotrexate. Arch Neurol 29:96–102, 1973

    Google Scholar 

  17. Ward HWC: CCNU in treatment of recurrent medulloblastoma. Br Med J 1:642, 1974

    Google Scholar 

  18. Garrett MJ, Hughs HJ, Ryall RDH: CCNU in brain tumors. Clin Radiol 25:183–184, 1974

    Google Scholar 

  19. Wilson CB, Gutin P, Baldrey EB, Crafts D, Levin VA, Enot KJ: Single-agent chemotherapy of brain tumors. Arch Neurol 33:739–744, 1976

    Google Scholar 

  20. Ward HWC: Central nervous system tumors of childhood treated with CCNU, vincristine and radiation. Med Ped Oncol 4:315–320, 1978

    Google Scholar 

  21. Walker RW, Allen JC: Treatment of recurrent primary intracranial childhood tumors with cis-diamminedichioroplatinum. Ann Neurology 14:371–372, 1983

    Google Scholar 

  22. Bertolone SJ, Baum E, Krivit W, Hammond D: Phase II trial of cisplatinum diamino dichloride (CPDD) in recurrent childhood brain tumors: A CCSG trial. Proc Am Assoc Cancer Res 2:72, 1983

    Google Scholar 

  23. Fenin LG, Savaraj N, Ozarda AT Cisplatin in medulloblastoma with extracranial metastasis: A case report. Cancer Treat Rep 68:1307–1308, 1984

    Google Scholar 

  24. Sexauer CL, Khan A, Burger PC, Krischer JP, Van Eys J, Vats T, Ragab AH: Cis-Platinum in recurrent pediatric brain tumors: A POG Phase II study. Cancer 56:1497–1501, 1985

    Google Scholar 

  25. Stolzenberg J, Fischer JJ, Kligerman MM: Extradural metastasis in medulloblastoma 10 years after treatment. Am J Roent 108:71–74, 1970

    Google Scholar 

  26. Allen JC, Helson L: High-dose cyclophosphamide chemotherapy for recurrent CNS tumors in children. J Neurosurg 55:749–756, 1981

    Google Scholar 

  27. Wienblatt ME, Ortega JA, Huggins GR, Siegel SE: Dianhydrogalactitol in the treatment of children with primary brain tumors. Cancer Treat Rep 65:923–924, 1981

    Google Scholar 

  28. Levin VA, Edwards MSB, Gunn PH, Vestnys P, Fulton D, Seager M, Wilson CB: Phase II evaluation of dibromodulcitol in the treatment of recurrent medulloblastoma, ependymoma, and malignant astrocytoma. J Neurosurg 61:1063–1068, 1984

    Google Scholar 

  29. Finklestein JZ, Albo V, Ertel I, Hammond D: 5-(3,3-Dimethyl-l-triazano)imidazole-4-carboxamide in the treatment of solid tumors in children. Cancer Chemother Rep 59:351–357, 1975

    Google Scholar 

  30. Norrell H, Wilson C: Brain tumor chemotherapy with methotrexate given intrathecally. JAMA 201:93–95, 1967

    Google Scholar 

  31. Newton WA, Sayers JP, Samuels LD: Intrathecal methotrexate therapy for brain tumors in children. Cancer Chemother Rep 52:257–261, 1968

    Google Scholar 

  32. Wilson CB, Norrell HA: Brain tumor chemotherapy with intrathecal methotrexate. Cancer 23:1038–1045, 1969

    Google Scholar 

  33. Sayers MP: Surgery and chemotherapy of brain tumors in children. Progr Exp Tumor Res 17:414–442, Karger, Basel, 1972

    Google Scholar 

  34. Norrell H, Wilson CB, Slagel DE, Clark DB: Leukoencephalopathy following the administration of methotrexate into the cerebrospinal fluid in the treatment of primary brain tumors. Cancer 33:923–932, 1974

    Google Scholar 

  35. Rosen G, Ghavimi F, Nirenberg A, Mosende C, Mehta BM: High dose methotrexate with citrovorum factor rescue for the treatment of central nervous system tumors in children. Cancer Treat Rep 61:681–690, 1977

    Google Scholar 

  36. Djerassi I, Kim JS, Shulman K: High-dose methotrexatecitrovorum factor rescue in the management of brain tumors. Cancer Treat Rep 61:691–694, 1977

    Google Scholar 

  37. Abelson HT, Kufe DW, Skarin AT, Major P, Ensminger W, Beardsley GP, Canellos GP: Treatment of central nervous system tumors with methotrexate. Cancer Treat Rep (Supp 1) 65:137–140, 1981

    Google Scholar 

  38. Mooney C, Souhami R, Pritchard J: Recurrent medulloblastoma — lack of response to high-dose methotrexate. Cancer Chemother Pharmacol 10:135–136, 1983

    Google Scholar 

  39. Borowska LF, Junkowska A, Kamraj-Mazurkiewica K: Cerebellar medulloblastoma metastases to skeletal system in children. Pol Przegl Radiol 33:429–434, 1969

    Google Scholar 

  40. Hancock C, Allen J, Tan CTC: Phase II trial of PCNU in children with recurrent brain tumors and Hodgkin's disease. Cancer Treat Rep 68:441–442, 1984

    Google Scholar 

  41. Kumar ARV, Renaudin J, Wilson CB, Boldrey EB, Enot KJ, Levin VA: Procarbazine hydrochloride in the treatment of brain tumors. J Neurosurg 40:365–371, 1974

    Google Scholar 

  42. Berry DH, Fernbach DJ, Sutow WW, Vietti TJ: Uracil mustard (NSC 34462) therapy in uncommon malignant neoplasms in children. Cancer Chemother Rep 52:441–443, 1968

    Google Scholar 

  43. Drachman DA, Winter TS, Karon M: Medulloblastoma with extracranial metastases. Arch Neurology 9:518–530, 1983

    Google Scholar 

  44. Haddy TB, Fernbach DJ, Watkins WL, Sullivan MP, Windmiller W. Vincristine in uncommon malignant disease in children. Cancer Chemother Rep 41:41–45, 1964

    Google Scholar 

  45. Lassman LP, Pearce GW, Gang J: Sensitivity of intracranial gliomas to vincristine sulphate. Lancet 1:296–298, 1965

    Google Scholar 

  46. Lassman LP, Pearce GW, Gang J: Effect of vincristine sulphate on the intracranial gliomata of childhood. Brit J Surg 53:774–777, 1966

    Google Scholar 

  47. Lampkin BC, Mauer AM, McBride BH: Response of medulloblastoma to vincristine sulfate: A case report. Ped 39:761–763, 1967

    Google Scholar 

  48. Smart CR, Ottoman RE, Rochlin DB, Hornes J, Silva AR, Goepfert H: Clinical experience with vincristine in tumors of the central nervous system and other malignant diseases. Cancer Chemother Rep 52:733–741, 1968

    Google Scholar 

  49. Lassman LP, Pearce GW, Banna M, Jones RD: Vincristine sulphate in the treatment of skeletal metastases from cerebellar medulloblastoma. J Neurosurg 30:42–49, 1969

    Google Scholar 

  50. Brutschin P, Culver GJ: Extracranial metastases from medulloblastomas. Neuroradiol 107:359–361, 1973

    Google Scholar 

  51. Afra D: Vincristine therapy in malignant glioma recurrences. Neurochirurgia 16:189–198, 1973

    Google Scholar 

  52. Rosenstock JG, Evans AE, Schut L: Response to vincristine of recurrent brain tumors in children. J Neurosurg 45:135–140, 1976

    Google Scholar 

  53. Christ WM, Ragab AH, Vietti TJ, Ducos R, Chu J-Y: Chemotherapy of childhood medulloblastoma. Am J Dis Child 13:639–642, 1976

    Google Scholar 

  54. Lassman LP: Diagnosis and management of skeletal metastases from cerebellar medulloblastoma. Child's Brain 2:38–45, 1976

    Google Scholar 

  55. Skylansky BD, Mann-Kaplan RS, Reynolds BF, Rosenblum ML, Walker MD: 4′-Demethyl-epipodophylotoxin-D-thenylidene-glucoside (PTG) in the treatment of malignant intracranial neoplasms. Cancer 33:460–467, 1974

    Google Scholar 

  56. Gutin PH, Wilson CB, Kumar ARV, Boldrey EB, Levin V, Powell M, Enot KJ: Phase II study of procarbazine, CCNU, and vincristine combination chemotherapy in the treatment of malignant brain tumors. Cancer 35:1398–1404, 1975

    Google Scholar 

  57. Crafts DC, Levin VA, Edwards MS, Pischer TL, Wilson CB: Chemotherapy of recurrent medulloblastoma with combined procarbazine, CCNU, vincristine. J Neurosurg 49:589–592, 1978

    Google Scholar 

  58. Levin VA, Vestnys PS, Edwards MS, Wara WM, Fulton D, Barger G, Seager M, Wilson CB: Improvement in survival produced by sequential therapies in the treatment of recurrent medulloblastoma. Cancer 51:1364–1370, 1983

    Google Scholar 

  59. Duffner PK, Cohen ME, Thomas PRM, Sinks LF, Freeman AI: Combination chemotherapy in recurrent medulloblastoma. Cancer 43:41–45, 1979

    Google Scholar 

  60. Seiler RW: Combination chemotherapy with VM26 and CCNU in primary malignant brain tumors of children. Helv Paediat Acta 35:51–56, 1980

    Google Scholar 

  61. Cangir A, Van Eys J, Berry DH, Hvizdala E, Morgan SK: Combination chemotherapy with MOPP in children with recurrent brain tumors. Med Ped Oncol 4:253–261, 1978

    Google Scholar 

  62. Cangir A, Ragab AH, Steuber P, Land VJ, Berry DH, Krischer JP: Combination chemotherapy with vincristine, procarbazine, prednisone with or without nitrogen mustard (MOPP vs OPP) in children with recurrent brain tumors. Med Ped Oncol 12:1–3, 1984

    Google Scholar 

  63. Lewis MD, Nunes LB, Powell DE, Schrader BI: Extra-axial spread of medulloblastoma. Cancer 71:1287–1297, 1973

    Google Scholar 

  64. Kessler LA, Dugan P, Concannon JP: Systemic metastases of medulloblastoma promoted by shunting. Surg Neurol 3:147–152, 1975

    Google Scholar 

  65. Hagler S, Currimbhay ZE, Tinsley M: Cerebellar medulloblastoma. Chemotherapeutic remission with vincristine, cyclophosphamide, and methotrexate. Cancer 21:912–919, 1968

    Google Scholar 

  66. Banna M, Lassman LP, Pearce GW: Radiological study of skeletal metastases from cerebellar medulloblastoma. Br J Radiol 43:173–179, 1970

    Google Scholar 

  67. Debnam JW, Staple TW. Osseous metastases from cerebellar medulloblastoma. Radiology 107:363–365, 1973

    Google Scholar 

  68. Parkinson D, Ross RT, Shields CB: Metastatic medulloblastoma. Le Journal Canadien Des Soences Neurologiques 1:253–254, 1974

    Google Scholar 

  69. Friedman HS, Mahaley Jr MS, Schold Jr SC, Vick NA, Bullard DE, D'Souza BJ, Falletta JM, Khandekar JD, Oakes WJ, Bigner DD: The efficacy of vincristine and cyclophosphamide in the therapy of recurrent medulloblastoma. Neurosurgery 18:335–340, 1986

    Google Scholar 

  70. Nathanson L, Kovacs SG: Chemotherapeutic response in metastatic medulloblastoma: Report of two cases and a review of the literature. 4:105–110, 1978

    Google Scholar 

  71. Ettinger LJ, Sinniah D, Siegel SE, Fishman LS, Segal HD, Soni D, Bennetts GA, Schultz DH, Raphael D: Combination chemotherapy with cyclophosphamide, vincristine, procarbazine and prednisone (COPP) in children with brain tumors. J neuro-Onc 3:263–270, 1983

    Google Scholar 

  72. Lee FH, Cannetta R, Issell BF, Lenaz L: New platinin complexes in clinical trials. Cancer Treat Rev 10:39–52, 1983

    Google Scholar 

  73. McAllister RM, Isaacs H, Rongey R, et at.: Establishment of a human medulloblastoma cell line. Int J Cancer 20:206–212, 1977

    Google Scholar 

  74. Friedman HS, Burger PC, Bigner SH, Trojanowski J, Wikstrand CJ, Halperin EC, Bigner DD: Establishment and characterization of the human medulloblastoma cell line and transplantable xenograft D283 Med. J Neuropathol Exp Neuro 44:592–605, 1985

    Google Scholar 

  75. Jacobsen PF, Jenkyn DJ, Papadimitriou JM: Establishment of a human medulloblastoma and its heterotransplantation into nude mice. J Neuropath Exp Neurol 44:472–485, 1985

    Google Scholar 

  76. Friedman HS, Bigner SH, McComb RD, Groothuis D, Pasternak J, Bigner DD: A model for human medulloblastoma — growth, morphology and chromosomal analysis In Vitro and in athymic mice. J Neuropathol Exp Neurol 42:485–503, 1983

    Google Scholar 

  77. Friedman HS, Schold Jr SC, Bjornsson T, Muhlbaier LH, Bigner DD: In vitro versus In vivo correlations of chemosensitivity of human medulloblastoma. Cancer Res 44:5145–49, 1984

    Google Scholar 

  78. Friedman HS, Schold Jr SC, Varia M, Bigner DD: Chemotherapy and radiation therapy of human medulloblastoma in athymic nude mice. Cancer Res 43:3088–93, 1983

    Google Scholar 

  79. Friedman HS, Schold Jr SC, Bigner DD: Chemotherapy of subcutaneous and intracranial human medulloblastoma xenografts in athymic nude mice. Cancer Res 46:224–228, 1986

    Google Scholar 

  80. Gerosa M, DiStefano E, Carli M, Iraci G: Combined treatment of pediatric medulloblastoma. Child's Brain 6:262–273, 1980

    Google Scholar 

  81. Woo SY, Sinks LF, Sackman-Murrel F, et al.: Update of adjuvant methotrexate and BCNU in treatment of medulloblastoma. Proc Am Assoc Can Res 2:66, 1983

    Google Scholar 

  82. McIntosh S, Chen M, Sartain PA, Duncan C, Fishburn R, Klatskin EH, Schwartz AD, Venes JL: Adjuvant chemotherapy for medulloblastoma. Cancer 56:1316–1320, 1985

    Google Scholar 

  83. Allen JC, Bloom J, Ertel I, Evans A, Hammond D, Jones H, Levin V, Jenkin D, Sposto R, Wara W: Brain tumors in children: Current cooperative and institutional chemotherapy trials in newly diagnosed and recurrent disease. Seminars III Oncology 13:110–122, 1986

    Google Scholar 

  84. Evans AE: (for the CCSG/RTOG Committees) Therapeutic approaches to medulloblastoma and results: The trial of the Children's Cancer Study Group (CCSG) and the Radiation Therapy Oncology Group (RTOG). In: Bloom HJG and Piehler E (ed) Proceedings of the 13th International Congress of Chemotherapy, SY 101, Part 208, Symposium: Chemotherapy for Brain Tumors in Children, Vienna, Austria, 1983

  85. Albright AL, Price RA, Guthkelch AN: Brainstem gliomas of children. A clinicopathologic study. Cancer 52:2313–2319, 1983

    Google Scholar 

  86. Stroink AR, Hoffman HJ, Hendrick EB, Humphreys RP: Diagnosis and management of pediatric brain-stem gliomas. J Neurosurg 65:745–750, 1986

    Google Scholar 

  87. Albright AL, Guthkelch AN, Packer RJ, Price RA, Rourke LB: Prognostic factors in pediatric brainstem tumors. J Neurosurg 65:751–755, 1986

    Google Scholar 

  88. Levin VA, Edwards MS, Wara WM, Allen J, Ortega J, Vestnys 1-(2-Chloroethyl)-3-cyclohexyl-l-nitrosourea (CCNU). Followed by hydroxyurea, misonidazole, and irradiation for brainstem gliomas: A pilot study of the Brain Tumor Research Center and the Children's Cancer Group. Neurosurgery 14:679–681, 1984

    Google Scholar 

  89. Rubin RC, Ommaya AK, Henderson ES, Bering EA, Rall DP: Cerebrospinal fluid perfusion for central nervous system neoplasms. Neurology 16:680–692, 1966

    Google Scholar 

  90. Friedman HS, Colvin OM, Hilton J, Schold Jr SC, Elion GB, Skapek SX, Blum MR, Savina PM, Muhlbaier LH, Bigner DD: Melphalan cytotoxicity and resistance in medulloblastoma. P Amer Assoc Can Res, (in press) 1987

Download references

Author information

Authors and Affiliations

  1. Departments of Pediatrics, Pathology, Duke University Medical Center, 27710, Durham, NC, USA

    Henry S. Friedman

  2. Departments of Pediatrics, Neurosurgery, Duke University Medical Center, 27710, Durham, NC, USA

    W. Jerry Oakes

Authors
  1. Henry S. Friedman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. Jerry Oakes
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Friedman, H.S., Oakes, W.J. The chemotherapy of posterior Fossa tumors in childhood. J Neuro-Oncol 5, 217–229 (1987). https://doi.org/10.1007/BF00151225

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00151225

Key words

Search

Navigation